Drugs for Neglected Diseases initiative

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

[Drugs for Neglected Diseases initiative @DNDi]

🤝 How do you use crowdsourcing to design medicines that could work against coronaviruses?

In this video, Fanny Escudié, our Senior Discovery Project Manager, shows how open science, AI, and global collaboration are accelerating discovery.

[International Pandemic Preparedness Secretariat @IPPSecretariat]

📣Updated statement:

The ongoing Bundibugyo ebolavirus (BDBV) outbreak in DRC shows pandemic risks can't be fully anticipated, and that preparedness must extend across viral families, including rare and neglected ones.

🧵 1/4

[Drugs for Neglected Diseases initiative @DNDi]

For years, sleeping sickness was one of the most difficult challenges that MSF doctors had to confront in Central Africa.
Today, 20 years after MSF & partners created DNDi, a single-dose treatment for this disease is ready to be distributed throughout the continent.
@MSF_canada

[Drugs for Neglected Diseases initiative @DNDi]

Today, we joined 7 PDPs to launch a call for sustained EU funding for EDCTP — supporting 20+ years of Europe–Africa clinical research, capacity strengthening, and innovation for global health security.
Learn more: https://t.co/fJVqAQ5DTP

[Drugs for Neglected Diseases initiative @DNDi]

🥵 Rising temperatures are bringing #dengue to Europe.
In this video, Sascha van Beek, German politician & nurse, explains why dengue is no longer a distant threat and why Germany & Europe need to prepare now.
👉Investing in dengue research & innovation is a global priority.

[Drugs for Neglected Diseases initiative @DNDi]

🎧 The third episode of our podcast is out!
Many of Dr @MawaAlyafrosi ’s patients are affected by cutaneous leishmaniasis, a parasitic disease that can lead to acute social stigma, particularly for women & children. 
Available on Spotify & Apple Podcasts: https://t.co/cVAq1B5Fck

[Drugs for Neglected Diseases initiative @DNDi]

It's been 10 years since @WHO recognized #Mycetoma as an #NTD.
Join us for a webinar "A Decade of Mycetoma Advocacy and Research: Lessons Learned & the Future" as we reflect on improving diagnosis, treatment & access. @MycetomaRC
Register https://t.co/OFRgRIkNTM   
#MycetomaAt10

[Global Health EDCTP3 @EDCTP3]

The Democratic Republic of the Congo has approved the use of Acoziborole Winthrop, a single-dose oral treatment for gambiense sleeping sickness.

Co-developed by @DNDi and @sanofi, and supported in part by @EDCTP3.

🔗 Learn more: https://t.co/VB4fj2LeHx

[Drugs for Neglected Diseases initiative @DNDi]

What does Malaysia need to better manage dengue?
Our Head of Dengue Global Program @siqueira__andre joins Dr Nor Fariza Ngah from @KKMPutrajaya on @bfmradio to discuss gaps in dengue response, most specifically the lack of treatments. 
🎧 https://t.co/JXAP3qwTm8

[Drugs for Neglected Diseases initiative @DNDi]

This study in @PLOSNTDs found that 65% of visceral #leishmaniasis patients in Ethiopia would have been excluded from Phase III trials. These patients had higher mortality and greater care needs: we need for more inclusive research! https://t.co/moResB1AGL

[Drugs for Neglected Diseases initiative @DNDi]

How do we close the diagnostic gap for #Chagas disease? With only about 10% of people diagnosed and 1% receiving care, experts have defined priorities for better rapid & molecular diagnostics and improved access to care. @BioMedCentral https://t.co/bPplTFJyaX

[Drugs for Neglected Diseases initiative @DNDi]

Children are among those most affected by dengue, yet no approved treatments exist.

We welcome @who’s 1st guidance on paediatric drug optimization, a big step towards accelerating child-friendly treatments.

Proud to contribute as part of the GAPf network https://t.co/a1YBthoQ7O

[Medicines for Malaria Venture (MMV) @MedsforMalaria]

MMV & @DNDi launch the first joint regulatory sciences platform between PDPs! By bringing together regulatory expertise, we can:

→ Pool knowledge & speak with one voice
→ Define evidence standards for future medicines
→ Strengthen impact

Read more: https://t.co/kMxfqPwkqc

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

A new @ProSyn op-ed argues that global health reform must not come at the expense of innovation.

Writing amid growing calls for a more efficient and country-led global health architecture, Manica Balasegaram (GARDP), Martin Fitchet (@MedsforMalaria) and Luis Pizarro (@DNDi) caution against overlooking one of the system's most important functions: developing new medicines, vaccines and diagnostics.

As drug resistance rises and pathogens evolve, the authors make the case for strengthening Product Development Partnerships (PDPs), which have delivered more than 79 health tools to 2.4 billion people.

📰🔗Read more:
https://t.co/P515x9HhFx

#GlobalHealth #AMR #Innovation

@Manica_amr

[Medicines for Malaria Venture (MMV) @MedsforMalaria]

We cannot meet today’s health needs with yesterday’s tools.

Improving coordination & delivery while neglecting #innovation risks creating a system that is better organized but not more effective.

Leaders from MMV, @DNDi & @gardp_amr explain why: https://t.co/JM3ZVVbmpb

[GHTC @GHTCoalition]

Last week, @DNDi, @MedsforMalaria, and @gardp_amr announced a new agreement to explore how the organizations can work together to advance global health R&D amid global aid cuts and calls to reshape the global health architecture.

https://t.co/s24Z7Ls2Lg

[Drugs for Neglected Diseases initiative @DNDi]

“What we’re trying to show is that it's not just about our organisations: it's about this model of working together,” says Luis Pizarro, our Executive Director, in @GenevaSolutions on the strategic agreement signed by DNDi, @gardp_amr & @MedsforMalaria.

https://t.co/9jc4Fi613y

[Drugs for Neglected Diseases initiative @DNDi]

@sanjayssarin @aajtak @nvbdcpmohfw @ICMRDELHI

[Drugs for Neglected Diseases initiative @DNDi]

Our Asia Continental Lead, @sanjayssarin, joined @aajtak's panel discussion on #dengue awareness & prevention. As dengue continues to spread to new areas, strengthening prevention, surveillance & research for safe & effective treatments is a priority.
https://t.co/w3t6lRJu6b

[Drugs for Neglected Diseases initiative @DNDi]

Dengue can develop into life-threatening complications known as severe dengue. Yet, there is still no specific treatment available.
Together with our partners, we're working to change this.
📣 Share this post to raise awareness this #WorldDengueDay

#OneWorldAgainstDengue